Canadian (TSX) Life Sciences Industry Analysis
UpdatedSep 15, 2023
DataAggregated Company Financials
Companies4
- 7D-4.5%
- 3M-15.8%
- 1Y-17.5%
- YTD-8.7%
Over the last 7 days, the Life Sciences industry has dropped 6.2%, driven by a pullback from Sona Nanotech of 9.5%. On the other hand Rapid Dose Therapeutics is actually up 27%. The industry has fallen 18% in the last year.
Industry Valuation and Performance
Has the Canadian Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 16 Sep 2023 | CA$196.4m | CA$23.7m | -CA$24,644,997.00 | n/a | -8x | 8.3x |
| Mon, 14 Aug 2023 | CA$197.4m | CA$23.5m | -CA$24,780,404.00 | n/a | -8x | 8.4x |
| Wed, 12 Jul 2023 | CA$198.9m | CA$23.5m | -CA$24,780,404.00 | n/a | -8x | 8.5x |
| Fri, 09 Jun 2023 | CA$174.0m | CA$22.5m | -CA$25,042,100.00 | n/a | -6.9x | 7.7x |
| Sun, 07 May 2023 | CA$173.7m | CA$22.5m | -CA$24,991,382.00 | n/a | -6.9x | 7.7x |
| Tue, 04 Apr 2023 | CA$188.7m | CA$23.0m | -CA$29,977,765.00 | 39x | -6.3x | 8.2x |
| Thu, 02 Mar 2023 | CA$192.4m | CA$23.0m | -CA$29,977,765.00 | 39x | -6.4x | 8.4x |
| Sat, 28 Jan 2023 | CA$190.8m | CA$22.4m | -CA$30,499,829.00 | 39x | -6.3x | 8.5x |
| Mon, 26 Dec 2022 | CA$190.2m | CA$22.4m | -CA$30,499,829.00 | 35.1x | -6.2x | 8.5x |
| Wed, 23 Nov 2022 | CA$198.0m | CA$21.8m | -CA$30,309,915.00 | 39.1x | -6.5x | 9.1x |
| Fri, 21 Oct 2022 | CA$214.2m | CA$21.7m | -CA$30,373,079.00 | 72.1x | -7.1x | 9.9x |
| Sun, 18 Sep 2022 | CA$201.7m | CA$21.7m | -CA$30,373,079.00 | 76.6x | -6.6x | 9.3x |
| Tue, 16 Aug 2022 | CA$208.2m | CA$21.9m | -CA$23,995,882.00 | 21.2x | -8.7x | 9.5x |
| Thu, 14 Jul 2022 | CA$159.0m | CA$21.5m | -CA$26,689,749.00 | 20.5x | -6x | 7.4x |
| Sat, 11 Jun 2022 | CA$179.6m | CA$21.5m | -CA$26,689,749.00 | 19.9x | -6.7x | 8.4x |
| Mon, 09 May 2022 | CA$213.7m | CA$21.5m | -CA$26,635,227.00 | 18.6x | -8x | 9.9x |
| Wed, 06 Apr 2022 | CA$200.4m | CA$21.6m | -CA$23,635,914.00 | 25.2x | -8.5x | 9.3x |
| Fri, 04 Mar 2022 | CA$181.1m | CA$21.3m | -CA$21,103,914.00 | 27.3x | -8.6x | 8.5x |
| Sun, 30 Jan 2022 | CA$224.5m | CA$20.9m | -CA$20,076,847.00 | 26.6x | -11.2x | 10.7x |
| Tue, 28 Dec 2021 | CA$238.7m | CA$20.9m | -CA$20,076,847.00 | 28x | -11.9x | 11.4x |
| Thu, 25 Nov 2021 | CA$254.7m | CA$21.0m | -CA$14,997,109.00 | 30x | -17x | 12.1x |
| Sat, 23 Oct 2021 | CA$243.0m | CA$20.7m | -CA$14,899,797.00 | 26.6x | -16.3x | 11.8x |
| Mon, 20 Sep 2021 | CA$255.0m | CA$20.7m | -CA$11,409,216.00 | 20.5x | -22.4x | 12.4x |
| Wed, 18 Aug 2021 | CA$244.9m | CA$20.7m | -CA$11,409,216.00 | 20.4x | -21.5x | 11.9x |
| Wed, 02 Jun 2021 | CA$208.1m | CA$19.7m | -CA$8,769,932.00 | 23.9x | -23.7x | 10.6x |
| Sat, 06 Mar 2021 | CA$332.2m | CA$18.4m | -CA$3,146,070.00 | 63x | -105.6x | 18.1x |
| Tue, 08 Dec 2020 | CA$169.9m | CA$17.7m | -CA$2,528,358.00 | 131.1x | -67.2x | 9.6x |
Price to Earnings Ratio
-68.1x
Current Industry PE
- Investors are pessimistic on the Canadian Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 10.7x is higher than the industry's current PS ratio of 8.4x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 14% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Trends
Which industries have driven the changes within the Canadian Healthcare industry?
| CA Market | 2.58% | |
| Healthcare | 5.78% | |
| Life Sciences | -4.54% | |
| Clinical Research and Equipment | -4.54% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| TELI Telescope Innovations | CA$0.27 | 20.0% +CA$2.4m | 3.8% | PS4.9x | |
| DOSE Rapid Dose Therapeutics | CA$0.12 | 15.0% +CA$1.6m | n/a | PS13.3x |